Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
作者信息
Yip Christina Y C, Yap Eng Soo, De Mel Sanjay, Teo Winnie Z Y, Lee Chun-Tsu, Kan Sheryl, Lee Melvin C C, Loh Will N H, Lim Er Luen, Lee Shir Ying
机构信息
Division of Haematology, Department of Laboratory Medicine, National University Hospital, Singapore City, Singapore.
Department of Haematology-Oncology, National University Cancer Institute, Singapore City, Singapore.
出版信息
Br J Haematol. 2020 Jul;190(1):33-36. doi: 10.1111/bjh.16847. Epub 2020 Jun 2.
Abstract
摘要
相似文献
1
Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
Br J Haematol. 2020 Jul;190(1):33-36. doi: 10.1111/bjh.16847. Epub 2020 Jun 2.
2
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Am J Hematol. 2020 Jul;95(7):861-862. doi: 10.1002/ajh.25834. Epub 2020 Apr 28.
3
Sex differences in COVID-19 course and outcome: progesterone should not be neglected.
J Appl Physiol (1985). 2020 Nov 1;129(5):1007-1008. doi: 10.1152/japplphysiol.00740.2020.
4
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
Br J Haematol. 2020 Jun;189(6):1062-1063. doi: 10.1111/bjh.16780. Epub 2020 May 19.
5
Cell-Free Therapies: Novel Approaches for COVID-19.
Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.
6
First case of persistent pancytopenia associated with SARS-CoV-2 bone marrow infiltration in an immunocompromised patient.
Ann Oncol. 2020 Oct;31(10):1418-1419. doi: 10.1016/j.annonc.2020.06.016. Epub 2020 Jun 29.
7
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
J Glob Antimicrob Resist. 2020 Sep;22:862-863. doi: 10.1016/j.jgar.2020.07.029. Epub 2020 Aug 15.
8
COVID-19 cytokine storm: the interplay between inflammation and coagulation.
Lancet Respir Med. 2020 Jun;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2. Epub 2020 Apr 27.
9
Covid-19 antibody tests: a briefing.
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
10
The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
Thromb Res. 2020 Jul;191:26-27. doi: 10.1016/j.thromres.2020.04.031. Epub 2020 Apr 27.
引用本文的文献
1
A Review of Hematological Complications and Treatment in COVID-19.
Hematol Rep. 2023 Oct 13;15(4):562-577. doi: 10.3390/hematolrep15040059.
2
An inexpensive and rapid diagnostic method for detection of SARS-CoV-2 RNA by loop-mediated isothermal amplification (LAMP).
MethodsX. 2023;10:102011. doi: 10.1016/j.mex.2023.102011. Epub 2023 Jan 11.
3
Evaluation of Blood Biochemistry and Cardiopulmonary status of Hospitalized Covid-19 Patients in 3 Months Post Discharged Follow up Survey.
Clin Med Insights Circ Respir Pulm Med. 2022 Dec 22;16:11795484221119332. doi: 10.1177/11795484221119332. eCollection 2022.
4
Hematologic Complications in Patients Hospitalized with COVID-19 Infection.
Hematol Rep. 2022 Jul 11;14(3):228-234. doi: 10.3390/hematolrep14030031.
5
Definition of the Immune Parameters Related to COVID-19 Severity.
Front Immunol. 2022 Mar 18;13:850846. doi: 10.3389/fimmu.2022.850846. eCollection 2022.
6
Biomarkers during COVID-19: Mechanisms of Change and Implications for Patient Outcomes.
Diagnostics (Basel). 2022 Feb 16;12(2):509. doi: 10.3390/diagnostics12020509.
7
Changes of Routine Hematological Parameters in COVID-19 Patients: Correlation with Imaging Findings, RT-PCR and Outcome.
Iran J Pathol. 2022 Winter;17(1):37-47. doi: 10.30699/IJP.2021.533645.2675. Epub 2021 Dec 15.
8
A systematic meta-analysis of immune signatures in patients with COVID-19.
Rev Med Virol. 2021 Jul;31(4):e2195. doi: 10.1002/rmv.2195. Epub 2020 Nov 20.
9
A machine learning PROGRAM to identify COVID-19 and other diseases from hematology data.
Future Sci OA. 2021 Jun 12;7(7):FSO733. doi: 10.2144/fsoa-2020-0207. eCollection 2021 Aug.
10
Extended Inflammation Parameters (EIP) as Markers of Immune System Cell Activation in Psoriasis.
Int J Inflam. 2021 Jun 14;2021:9216528. doi: 10.1155/2021/9216528. eCollection 2021.
本文引用的文献
1
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
Br J Haematol. 2020 May;189(3):428-437. doi: 10.1111/bjh.16659. Epub 2020 Apr 20.
2
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.
Nat Med. 2020 Apr;26(4):453-455. doi: 10.1038/s41591-020-0819-2.
3
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
4
COVID-19 infection: the perspectives on immune responses.
Cell Death Differ. 2020 May;27(5):1451-1454. doi: 10.1038/s41418-020-0530-3. Epub 2020 Mar 23.
5
Hematologic parameters in patients with COVID-19 infection.
Am J Hematol. 2020 Jun;95(6):E131-E134. doi: 10.1002/ajh.25774. Epub 2020 Mar 19.
6
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Coronavirus infections and immune responses.
J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7.
10
Identification and quantification of high fluorescence-stained lymphocytes as antibody synthesizing/secreting cells using the automated routine hematology analyzer XE-2100.
Cytometry B Clin Cytom. 2007 May;72(3):157-66. doi: 10.1002/cyto.b.20150.
Zotero 插件